Most cysts are benign fluid-filled sacs that never become cancer, but a small fraction harbor malignant cells or carry the potential to transform over time. No single test gives a definitive answer on its own. Instead, doctors piece together clues from imaging, fluid analysis, blood markers, and sometimes biopsy to decide whether a cyst is dangerous. The features that raise suspicion depend heavily on where the cyst sits in the body, and the tools used to evaluate a kidney cyst look very different from those used for an ovarian or pancreatic one.
What Makes a Cyst Look Suspicious on Imaging
The first line of evaluation for almost any cyst is some form of imaging, usually ultrasound, CT, or MRI. Radiologists look for a handful of structural red flags that distinguish a simple, harmless cyst from one that deserves further workup. A purely fluid-filled sac with thin, smooth walls and no internal structures is almost always benign. Trouble starts when certain features appear.
For ovarian cysts, researchers developed a set of five “simple rules” that predict malignancy on ultrasound: an irregular solid tumor, fluid buildup in the abdomen (ascites), four or more papillary projections inside the cyst, an irregular multilocular-solid mass at least 10 cm across, and very high blood flow on Doppler imaging.1PubMed. Simple ultrasound-based rules for the diagnosis of ovarian cancer A more recent multicenter study confirmed that several of those same features, including solid components, irregular inner walls, high color scores on Doppler, and ascites, independently predict malignancy, while acoustic shadowing (a sign often linked to benign dermoid cysts or fibroids) actually acts as a protective factor.2International Journal of Women’s Health. A Simple O-RADS-Based Ultrasound Scoring System for Risk Stratification of Ovarian Cystic Lesions: A Multicenter Study
For kidney cysts, the Bosniak classification system has been the standard for over three decades.3PubMed Central. Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment It sorts cysts into categories based on how complex they look on CT or MRI: thin vs. thick walls, the number and thickness of internal dividers (septa), whether parts of the cyst light up after contrast dye, and whether there are solid nodules. A Bosniak I cyst is a simple water-density sac with essentially no cancer risk. At the other end, a Bosniak IV lesion has clearly enhancing solid tissue and is almost certainly malignant.
Pancreatic cysts get evaluated along similar lines. On imaging, mucinous cystic neoplasms can appear as large cysts with multiple compartments, a thick outer wall, internal dividers, and enhancing nodules growing from the wall. Mural nodules, wall thickening, and calcifications are the features most linked to malignancy.4PubMed Central. Evaluation of cystic neoplasms using EUS, MRI, and CT scan and treatment strategy
How the Numbers Break Down by Organ
Knowing the general warning signs is helpful, but the actual risk of cancer varies enormously depending on what organ the cyst is in, how big it is, and what classification it receives.
Kidney Cysts
A large meta-analysis found that the malignancy rate climbs steeply as Bosniak category rises: roughly 3% for category I, about 6% for category II, around 7% for category IIF, about 55% for category III, and roughly 91% for category IV.5PubMed Central. Malignancy rates and diagnostic performance of the Bosniak classification for the diagnosis of cystic renal lesions in computed tomography – a systematic review and meta-analysis A single-center study looking specifically at Bosniak III lesions found that 60% turned out to be malignant after surgery, though all of those cancers were low-grade with no sign of progression to more aggressive disease.6PubMed Central. The true malignancy risk of Bosniak III cystic renal lesions: Active surveillance or surgical resection? That finding underlines an important nuance: even when a cystic kidney mass does contain cancer, it is often slow-growing and unlikely to spread.
MRI can sometimes pick up details CT misses. In a head-to-head comparison, MRI detected more septa or thicker walls than CT in roughly one in five to one in eight cysts, which led to a classification upgrade in about 10% of cases, sometimes pushing a cyst from a “probably fine, watch it” category into a “probably needs surgery” one.7PubMed. Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system
Ovarian Cysts
The majority of ovarian cysts in premenopausal women are functional, meaning they form as a normal part of the menstrual cycle and resolve on their own. When an ovarian cyst does turn out to be cancerous, outcomes depend heavily on how early it is caught. About three-quarters of ovarian cancer patients present with advanced disease (stage III or IV), and while most of those women respond to initial treatment, the cancer recurs in nearly all of them.8The Lancet. Ovarian cancer This is why doctors take suspicious ovarian cysts seriously even when the odds of cancer are statistically low in younger women. Ultrasound-based scoring systems like the SRU guidelines have been shown to effectively stratify risk, with higher ratings strongly predicting malignancy.9PubMed. Risk Stratification of Adnexal Cysts and Cystic Masses: Clinical Performance of Society of Radiologists in Ultrasound Guidelines
Pancreatic Cysts
Pancreatic cysts are increasingly found by accident on abdominal scans done for unrelated reasons. Not all types carry malignant potential. Some, like serous cystadenomas and simple fluid collections, do not become cancerous. Others, including intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms, can progress to cancer and need to be monitored or removed depending on their features. Small pancreatic cysts under about 15 mm at diagnosis carry a very low risk of malignant transformation, and that risk appears to decrease further over time. The strongest predictor of trouble is rapid growth, specifically a size increase of 2.5 mm or more per year.10PubMed Central. Risk of malignancy in small pancreatic cysts decreases over time
Breast Cysts
Simple breast cysts, the kind that feel smooth and movable and show up as fluid-filled on ultrasound, are not themselves cancerous. But having palpable breast cysts is associated with a modestly higher future risk of developing breast cancer compared to the general population. One large follow-up study found that women with palpable cysts had roughly three times the expected rate of breast cancer. The relative risk was highest in women under 45, where it was nearly six times the background rate, with the relative increase tapering with age.11The Lancet. Breast cancer incidence in women with palpable breast cysts This does not mean the cyst itself becomes cancer. Rather, having cysts seems to be a marker for breast tissue that is at higher overall risk.
Why Biopsy Alone Does Not Always Settle the Question
You might assume that sticking a needle into a cyst and examining the cells under a microscope would give a clear answer. For solid tumors, biopsy is indeed the gold standard. For cystic lesions, the picture is murkier.
Pancreatic cysts are the clearest example of this problem. Cytology, the process of examining cells extracted from cyst fluid, has poor sensitivity for detecting mucinous or high-risk cysts. A meta-analysis of studies using fine needle aspiration alongside newer through-the-needle biopsy techniques found that cytology alone caught only about 46% of mucinous cysts and about 38% of high-risk cysts, though when it did flag something, it was rarely wrong (specificity was around 90% or higher).12PubMed. Diagnostic accuracy of EUS-guided through-the-needle-biopsies and simultaneously obtained fine needle aspiration for cytology from pancreatic cysts: A systematic review and meta-analysis In other words, a positive finding on cyst fluid cytology is trustworthy, but a negative one does not mean you are in the clear. Because of this, clinical guidelines often rely on imaging features and clinical context to guide decisions about surgery or surveillance rather than cytology alone.13PubMed Central. Screening for pancreatic cancer: what can cyst fluid analysis tell us?
For pancreatic cystic tumors more broadly, pathology can be tricky even after surgical removal. In one series of 67 patients, the epithelial lining of the tumor was partially or almost entirely absent in 40% to 72% of cases depending on the tumor type, leading to misdiagnoses even on permanent pathology slides.14PubMed Central. Cystic tumors of the pancreas. New clinical, radiologic, and pathologic observations in 67 patients When the lining that would reveal the cyst’s nature is largely absent, pathologists can struggle to classify the lesion correctly.
Blood Markers and Cyst Fluid Chemistry
Blood tests and cyst fluid analysis can provide additional clues, though they rarely give a definitive answer in isolation. For pancreatic cysts, the tumor marker CA 19-9 measured in blood tends to be significantly elevated in ductal carcinomas and mucinous cystic neoplasms. When researchers combined serum CA 19-9 with another marker (CA 72-4) measured in the cyst fluid itself, the combination correctly identified 95% of pre-malignant or malignant lesions, with only one false positive.15Cancer. Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors These markers are not yet part of routine screening protocols for everyone with a pancreatic cyst, but they can add useful information when the imaging is ambiguous.
For ovarian cysts, the most commonly used blood marker is CA-125, which tends to be elevated in epithelial ovarian cancer. It is far from perfect, however: CA-125 can be elevated in endometriosis, pelvic inflammatory disease, liver disease, and even during normal menstruation. Doctors typically interpret CA-125 alongside imaging findings and clinical context rather than relying on it alone.
Skin Cysts and Their Look-Alikes
Skin cysts, particularly epidermoid and sebaceous cysts, are extremely common and almost never cancerous. They usually present as firm, round bumps just under the skin, often with a visible central pore. They move freely when you push on them and grow slowly over months or years. The main concern with skin cysts is not that they will become cancer but that cancer can sometimes mimic them.
Metastatic cancer from internal organs occasionally shows up as a skin nodule that looks, on first glance, like an ordinary cyst. Skin metastases can masquerade as cysts, hemangiomas, and several other common dermatological conditions.16PubMed. Skin metastasis: a pathologist’s perspective Red flags that a supposed skin cyst might be something else include rapid growth, a hard or fixed consistency (rather than the soft mobility of a benign cyst), ulceration or bleeding, irregular borders, and appearing in an unusual location for ordinary cysts. Any lump that is growing quickly, feels attached to deeper tissue, or looks inflamed without an obvious cause is worth having a doctor examine.
When Doctors Watch and Wait Instead of Operating
Not every suspicious cyst needs immediate surgery. For many cystic lesions, active surveillance, meaning regular imaging over time, is a reasonable and increasingly accepted approach.
Small kidney masses, including complex cysts under 4 cm, tend to grow slowly and rarely spread. Urological guidelines now recognize active surveillance as a valid option for these cases, particularly in older patients or those who are not good candidates for surgery. The growth rate and risk of metastasis for small renal masses are extremely low.17SpringerOpen / Insights into Imaging. Active surveillance of small renal masses Surveillance typically involves repeat CT or MRI scans at set intervals, watching for changes in size or complexity that would tip the balance toward intervention.
For pancreatic cysts, the same principle applies. Small cysts without worrisome features can be followed with imaging. Cysts with high-risk features, such as mural nodules or main duct involvement, are usually recommended for surgical removal if the patient is healthy enough to tolerate the operation. The challenge is that pancreatic surgery carries its own meaningful risks, so the decision always involves weighing the probability of cancer against the hazards of the procedure itself.
When Benign Masses Mimic Cancer
One of the underappreciated challenges in evaluating cystic masses is that benign conditions can look alarmingly like cancer on imaging. In the bladder, for instance, a variety of non-cancerous conditions, including inflammatory masses and other benign growths, can produce focal lumps or wall thickening that closely resemble malignant tumors on imaging.18PubMed. From the archives of the AFIP: Inflammatory and nonneoplastic bladder masses: radiologic-pathologic correlation Infected cysts, hemorrhagic cysts (ones that have bled internally), and abscesses can all develop thick walls, internal debris, and increased blood flow that mimic the hallmarks of malignancy. This is one reason doctors often recommend follow-up imaging after treating an infection or waiting for a hemorrhagic cyst to resolve, to see whether the “suspicious” features disappear once the acute process settles down.
Cysts in Children vs. Adults
The approach to evaluating cysts changes significantly when the patient is a child. Certain cyst types carry very different implications depending on age. Choledochal cysts, which form in the bile ducts, illustrate this clearly. In a comparison of pediatric and adult patients, none of the children with choledochal cysts had malignant transformation, whereas about 21% of adults did.19Journal of Gastrointestinal Surgery. Choledochal Cysts: Differences Between Pediatric and Adult Patients Children were also more likely to present with a palpable abdominal mass and less likely to have abdominal pain, while adults had higher rates of complications including gallstones and long-term surgical problems.20JAMA Surgery. Presentation and Clinical Outcomes of Choledochal Cysts in Children and Adults: A Multi-institutional Analysis
More broadly, cystic masses in children are far more likely to be developmental or congenital in origin than cancerous. Ovarian cysts in pediatric patients are overwhelmingly benign, and renal cysts in children are rare enough that when they do appear, they often point to a genetic condition rather than cancer. The threshold for concern is lower in adults partly because the baseline risk of malignancy rises with age.
AI and Radiomics in Cyst Evaluation
One of the most active areas of research in cyst evaluation is the use of artificial intelligence to extract patterns from imaging that human eyes cannot reliably detect. This field, broadly called radiomics, involves pulling hundreds or thousands of quantitative features from a CT or MRI scan and feeding them into machine learning algorithms that learn to distinguish benign from malignant cysts.
For pancreatic cysts, where the existing diagnostic tools have well-known blind spots, this approach has shown promising early results. A study using multiple machine learning classifiers on preoperative CT images achieved accuracy above 93% across training, internal test, and external test groups, with similar performance in a prospective validation group.21PubMed Central. Machine Learning-Based Radiomics in Malignancy Prediction of Pancreatic Cystic Lesions: Evidence from Cyst Fluid Multi-Omics Researchers have also explored how radiomics could help differentiate mucinous from non-mucinous pancreatic cysts and identify high-risk IPMNs, potentially guiding clinical decisions and reducing unnecessary surgeries.22PubMed Central. Radiomics in stratification of pancreatic cystic lesions: Machine learning in action A 2026 narrative review noted that while results are encouraging, most studies so far have been retrospective and involve relatively small patient numbers, so clinical adoption is still a ways off.23PubMed. Radiomics and artificial intelligence in pancreatic cyst characterization: future or fiction?
The appeal of these tools is clear: if software could reliably identify which pancreatic cysts need surgery and which can be safely watched, it would spare many patients from major operations they did not need while catching the dangerous cysts earlier. For now, though, AI-based evaluation remains a research tool rather than a routine clinical one.
What Aggressive Tumors Look Like Internally
When a solid tumor grows very fast, it can outstrip its own blood supply in the center, creating a dead zone of necrotic tissue that fills with fluid and can look cyst-like on imaging. This is not the same thing as a cyst that became cancerous; it is a cancer that developed a cyst-like core. Necrosis inside a tumor is actually associated with more aggressive behavior and a higher risk of the cancer spreading. Research on breast cancer models has shown that the necrotic zone promotes changes in local blood vessels that can facilitate the release of circulating tumor cells, essentially creating a highway for metastasis from the tumor’s interior.24PubMed Central. Metastasis from the tumor interior and necrotic core formation are regulated by breast cancer-derived angiopoietin-like 7 On imaging, a mass with a fluid-filled or necrotic center surrounded by an irregular, thick, enhancing rim is treated very differently from a simple cyst. The rim of living tissue, the irregular borders, and the contrast enhancement all point toward malignancy rather than a benign cystic process.
Understanding this distinction matters because patients sometimes hear the word “cyst” in a radiology report and assume it means benign. A “cystic component” within an otherwise solid and irregular mass is not reassuring in the way a simple, thin-walled, fluid-only cyst is. Context is everything, and the description of what surrounds the fluid matters at least as much as the fluid itself.